Hosted on MSN
FDA beats EMA to most approved new drugs in 2024
The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies ...
Cellectar Biosciences, Inc. announced its intention to seek conditional approval from the European Medicines Agency (EMA) for its drug iopofosine I 131 to treat Waldenstrom Macroglobulinemia, ...
X4 Pharmaceuticals announced the validation of its Marketing Authorization Application (MAA) for mavorixafor, a treatment for WHIM syndrome, by the European Medicines Agency (EMA). This rare primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results